D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder

被引:137
|
作者
Storch, Eric A. [1 ]
Merlo, Lisa J.
Bengtson, Michael
Murphy, Tanya K.
Lewis, Mark H.
Yang, Mark C.
Jacob, Marni L.
Larson, Michael
Hirsh, Adam
Fernandez, Melanie
Geffken, Gary R.
Goodman, Wayne K.
机构
[1] Univ Florida, Dept Psychiat, Gainesville, FL 32610 USA
[2] Univ Florida, Dept Pediat, Gainesville, FL 32610 USA
[3] Univ Florida, Dept Stat, Gainesville, FL 32610 USA
[4] Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL 32610 USA
关键词
D-cycloserine; exposure-response prevention therapy; obsessive-compulsive disorder; treatment;
D O I
10.1097/YIC.0b013e32819f8480
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Obsessive-compulsive disorder is a common, chronic, and oftentimes disabling disorder. The only established first-line treatments for obsessive-compulsive disorder are exposure and response prevention therapy and the serotonin reuptake inhibitors. Many patients do not experience complete symptom resolution with either modality and require augmentation approaches. Recent animal and clinical data suggest that D-cycloserine, a partial agonist that acts at the strychnine-insensitive glycine-recognition site of the N-methyl-D-aspartate receptor complex, may enhance extinction learning that occurs in exposure-based psychotherapies. Given this, this study examined if D-cycloserine (250 mg) enhances the overall efficacy and rate of change of exposure and response prevention therapy for adult obsessive-compulsive disorder. Participants were 24 adults meeting Diagnostic and Statistical Manual of Mental Disorders-IV criteria for obsessive-compulsive disorder. The study design was a randomized, double-blinded, placebo-controlled augmentation trial examining exposure and response prevention therapy+ D-cycloserine versus exposure and response prevention therapy+ placebo. All patients received 12 weekly sessions of exposure and response prevention treatment. The first session involved building a ritual hierarchy and providing psychoeducation about obsessive-compulsive disorder. The second session involved a practice exposure. Sessions 3-12 involved exposure and response prevention exercises. D-cycloserine or placebo (250 mg) was taken 4 h before every session. No significant group differences were found across outcome variables. The rate of improvement did not differ between groups. The present results fail to support the use Of D-cycloserine with exposure and response prevention therapy for adult obsessive-compulsive disorder. As this study is the first to explore this question and a number of methodological issues must be considered when interpreting the findings, the conclusions that may be drawn from our results are limited.
引用
收藏
页码:230 / 237
页数:8
相关论文
共 50 条
  • [31] Delivery of Exposure and Response Prevention Among Veterans with Obsessive-Compulsive Disorder
    Hertz, Alyssa G.
    Dawson, Darius B.
    Rassu, Fenan S.
    Ecker, Anthony H.
    Helm, Ashley
    Hundt, Natalie E.
    Fletcher, Terri L.
    JOURNAL OF BEHAVIORAL HEALTH SERVICES & RESEARCH, 2023, 50 (04): : 514 - 523
  • [32] High intensity approaches to exposure and response prevention for obsessive-compulsive disorder
    Trent, Erika S.
    Zhou, Robert J.
    Mammo, Liya
    Goodman, Wayne K.
    Storch, Eric A.
    BEHAVIOURAL BRAIN RESEARCH, 2025, 481
  • [33] Does d-Cycloserine Augmentation of CBT Improve Therapeutic Homework Compliance for Pediatric Obsessive–Compulsive Disorder?
    Jennifer M. Park
    Brent J. Small
    Daniel A. Geller
    Tanya K. Murphy
    Adam B. Lewin
    Eric A. Storch
    Journal of Child and Family Studies, 2014, 23 : 863 - 871
  • [34] Predictors of response to exposure and response prevention-based cognitive behavioral therapy for obsessive-compulsive disorder
    Sayo Hamatani
    Aki Tsuchiyagaito
    Masato Nihei
    Yuta Hayashi
    Tokiko Yoshida
    Jumpei Takahashi
    Sho Okawa
    Honami Arai
    Maki Nagaoka
    Kazuki Matsumoto
    Eiji Shimizu
    Yoshiyuki Hirano
    BMC Psychiatry, 20
  • [35] Predictors of response to exposure and response prevention-based cognitive behavioral therapy for obsessive-compulsive disorder
    Hamatani, Sayo
    Tsuchiyagaito, Aki
    Nihei, Masato
    Hayashi, Yuta
    Yoshida, Tokiko
    Takahashi, Jumpei
    Okawa, Sho
    Arai, Honami
    Nagaoka, Maki
    Matsumoto, Kazuki
    Shimizu, Eiji
    Hirano, Yoshiyuki
    BMC PSYCHIATRY, 2020, 20 (01)
  • [36] Treatment of obsessive-compulsive disorder: Cognitive behavior therapy vs. exposure and response prevention
    Whittal, ML
    Thordarson, DS
    McLean, PD
    BEHAVIOUR RESEARCH AND THERAPY, 2005, 43 (12) : 1559 - 1576
  • [37] An Avoidance-Based Rodent Model of Exposure With Response Prevention Therapy for Obsessive-Compulsive Disorder
    Rodriguez-Romaguera, Jose
    Greenberg, Benjamin D.
    Rasmussen, Steven A.
    Quirk, Gregory J.
    BIOLOGICAL PSYCHIATRY, 2016, 80 (07) : 534 - 540
  • [38] Efficacy of D-cycloserine augmented brief intensive cognitive-behavioural therapy for paediatric obsessive-compulsive disorder: A randomised clinical trial
    Farrell, Lara J.
    Waters, Allison M.
    Tiralongo, Evelin
    Mathieu, Sharna
    McKenzie, Matthew
    Garbharran, Vinay
    Ware, Robert S.
    Zimmer-Gembeck, Melanie J.
    McConnell, Harry
    Lavell, Cassie
    Cadman, Jacinda
    Ollendick, Thomas H.
    Hudson, Jennifer L.
    Rapee, Ronald M.
    McDermott, Brett
    Geller, Daniel
    Storch, Eric A.
    DEPRESSION AND ANXIETY, 2022, 39 (06) : 461 - 473
  • [39] Behavioral avoidance as a factor in concentrated exposure and response prevention for obsessive-compulsive disorder
    Wheaton, Michael G.
    Hagen, Kristen
    Bjorgvinsson, Throstur
    Kvale, Gerd
    Hansen, Bjarne
    JOURNAL OF OBSESSIVE-COMPULSIVE AND RELATED DISORDERS, 2024, 41
  • [40] D-cycloserine and exposure therapy
    Rothbaum, B.
    Davis, M.
    Ressler, K.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S170 - S170